Educational Chart Set ups

//Educational Chart Set ups

INSM 9.6.17

By | September 6th, 2017|Educational Chart Set ups|0 Comments

$TRIP 9.6.17

By | September 6th, 2017|Educational Chart Set ups|0 Comments

GLYC I went long today. Idea. 9.5.17

Persistence is what makes the impossible possible, the possible likely, and the likely definite. Stock popped 20% intra day and closed @ $13.97 or +18.19%. We took profits. Chart update Congrats on profits if follow. Thanks for reading. ~PT365   ~~~~~~~~~~~~~~~~~~~~~Original blog FREE trade idea on Sept 5, 2017~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ "Persistence is what makes [...]

By | September 5th, 2017|Educational Chart Set ups, Public Access|0 Comments

AXON, VSAR these two P3 biotech data in September for big move after INSM. Ideas 9.5.17

These are ideas and opinion only;  always do you own due diligence NASDAQ: INSM +119.61% on positive data of Phase 3 study. These two have Phase 3 data in September #AXON- MINDSET Phase 3 study results in late September 2017 http://investors.axovant.com/news-releases/news-release-details/axovant-announces-fiscal-first-quarter-financial-results-and  There are no current treatment for Alzheimer's disease, expect stock to make big move depending [...]

By | September 5th, 2017|Educational Chart Set ups, Public Access|0 Comments

Opinion- If I win Powerball’s 700M jackpot, these are biotech I’d invest. 8.23.17

**** Disclaimer: These stocks are opinion and ideas only. Always do your own due diligence. I hold long position in #SCYX.  If you don't know already, the Powerball's $700M jackpot is tonight; second largest prize in U.S. History. If you don't play, you don't win even if the odd is very small. Here [...]

By | August 23rd, 2017|Educational Chart Set ups, Public Access|0 Comments

RARE study did not achieve its primary endpoint. 8.22.17

#RARE  Ultragenyx Announces Top-Line Results from Phase 3 Study of Ace-ER in GNE Myopathy  http://globenewswire.com/news-release/2017/08/22/1091258/0/en/Ultragenyx-Announces-Top-Line-Results-from-Phase-3-Study-of-Ace-ER-in-GNE-Myopathy.html share resume 4:25PM ET

By | August 22nd, 2017|Educational Chart Set ups, Public Access|0 Comments

ACOR, FGEN two biotech stocks to watch in future. Ideas. 8.7.17

Acorda Therapeutics Inc (ACOR:NASDAQ)- Scopia Capital Management 16.5% stake owner. Wrote to the board urging review strategic alternative, including sales. https://finance.yahoo.com/news/activists-gonna-activate-hedge-funds-184154748.html  Fibrogen Inc (FGEN:NASDAQ)-  FibroGen Announces Positive Topline Results from Phase 2 Study of Pamrevlumab in Idiopathic Pulmonary Fibrosis https://finance.yahoo.com/news/fibrogen-announces-positive-topline-results-205050467.html Charts: Thanks for reading. ~PT365

By | August 7th, 2017|Educational Chart Set ups, Public Access|0 Comments

TWLO raises guidance, CEO bought share shows confidence. Idea. 8.7.17

Twilio Inc (TWLO:NYSE) earning reports: Q3 EPS (5c) vs (11c) est, revenue $95.9M vs $87.6M est. Sees FY17 EPS (24c)-(22c) vs (29c), revenue $371m-375m vs 359.8M est On May 10, 2017 , CEO Jeff Lawson bought 100,000 at $23.43 for value $2,343,180 https://www.sec.gov/Archives/edgar/data/1447669/000112760217017754/xslF345X03/form4.xml   Thanks for reading. ~PT365

By | August 7th, 2017|Educational Chart Set ups, Public Access|0 Comments

MDCO, ZYNE These two beat down biotech with upcoming data to watch. Idea. 8.3.17

Medicines CO (MDCO:NASDAQ)- Pending data TANGO 2 Phase 3 trial expect result available end of Q3 '17  http://www.themedicinescompany.com/investors/news/medicines-company-reports-first-quarter-2017-financial-results Company 2Q earning result will be on August 9, 2017 2.  Zynerba Pharmaceuticals Inc (ZYNE:NASDAQ)- "Top-line Phase 2 results for STAR 1 trial in epilepsy and STOP trial in osteoarthritis remain on track for reporting [...]

By | August 3rd, 2017|Educational Chart Set ups, Public Access|0 Comments

AMD, X. The bulls are coming: These two stocks with earning reports beat. public Idea to watch. 7.25.17

Stock and Macro calendar http://www.precisiontrade365.com/stock-and-macro-calendar/ Advanced Micro Devices, Inc (AMD:NASDAQ). Earning reports Q2 EPS 2c vs 0c est. Revenue $1.22B vs $1.16B est. Stock advance +8.43% to $15.30 after hours trading. Here a look at chart Technical United States Steel Corp (X:NYSE).  Q2 earning reports: EPS $1.48 vs 34c, revenue $3.14B vs $2.96B. After [...]

By | July 25th, 2017|Educational Chart Set ups, Public Access|0 Comments

Please contact us!

Please leave us your phone and we call you back!

We never share this data with 3rd part companies.

Thank you!
We got your message
We will answer in the next 24h